Suramin intravenous infusion for treating boys with autism spectrum disorder: results of a 14-week, randomized, double-blind, placebo-controlled, multidose, phase 2 study
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要